The Effect of GLP-1 on the Inhibition of Glucagon Secretion

NCT01507597 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Type 1 Diabetes

Interventions

DRUG: Native human Glucagon-like Peptide-1 ( GLP-1(7-36))
DRUG: NaCl
DRUG: Native human Glucagon-like Peptide-1 ( GLP-1(7-36))
DRUG: Native human Glucagon-like Peptide-1 ( GLP-1(7-36))

Sponsor

University Hospital, Gentofte, Copenhagen